Time course of the cerebral circulatory response to metabolic depression

Am J Physiol. 1978 Jan;234(1):H74-9. doi: 10.1152/ajpheart.1978.234.1.H74.

Abstract

Baboons anesthetized with halothane and N2O/O2 were given an intravenous steroid anesthetic (Althesin; Glaxo Laboratories Ltd., U.K.). The drug bolus was labeled with 99mTc, and the time from central venous injection to peak radioactivity in the brain was designated drug brain arrival (DBA-peak). The electroencephalogram slowed 1.2 +/- 0.9 s after DBA-peak (P greater than 0.2), and approximately 2 s after DBA-peak, internal carotid blood flow (ICarBF) decreased and calculated internal carotid vascular resistance (ICarVR) rose. During this 2-s delay in the cerebrovascular response to the arrival of a cerebral metabolic depressant in the brain, the decrease in mean cortical Pco2 was calculated to be less than 0.26 mmHg from cortical CO2 solubility, and less than 0.32 mmHg from cortical CO2 diffusivity, which indicated that mean cortical Pco2 changes do not control cerebral blood flow (CBF). The unaltered time course of the changes in EEG, ICarBF, and ICarVR after acute cervical sympathectomy and alpha-adrenergic receptor blockade excluded the involvement of the sympathetic nervous system in the vasoconstrictor response. Intracarotid Althesin showed that the cerebral vasoconstriction was not a direct effect of the drug. The postulated link between the effects of Althesin on CBF and cerebral metabolism remains to be elucidated but is probably indirect, involving the brainstem.

MeSH terms

  • Adrenergic alpha-Antagonists
  • Alfaxalone Alfadolone Mixture / pharmacology*
  • Animals
  • Blood Pressure / drug effects
  • Brain / metabolism*
  • Carotid Artery, Internal / physiology
  • Cerebrovascular Circulation*
  • Electroencephalography
  • Haplorhini
  • Papio
  • Pregnanediones / pharmacology*
  • Regional Blood Flow
  • Sympathectomy
  • Time Factors
  • Vascular Resistance / drug effects
  • Vasoconstriction / drug effects

Substances

  • Adrenergic alpha-Antagonists
  • Pregnanediones
  • Alfaxalone Alfadolone Mixture